» Articles » PMID: 11728784

Cocaine Dependence: a Disease of the Brain's Reward Centers

Overview
Specialty Psychiatry
Date 2001 Dec 1
PMID 11728784
Citations 115
Authors
Affiliations
Soon will be listed here.
Abstract

Cocaine addiction affects brain reward centers that have evolved to ensure survival. Cocaine euphoria is intensely pleasurable and results from mesolimbic dopamine (DA) neurotransmission. DA signal-receiving neurons in the nucleus accumbens synthesize endogenous opioids and project to numerous reward regions. Cocaine-induced neuroadaptations, including DA depletion, may underlie craving and hedonic dysregulation. Cue-induced craving is vigorously triggered by conditioned elements of the drug environment and associated with measurable limbic activation. Reduced frontal lobe metabolism in cocaine-addicted individuals could explain important clinical phenomena such as denial and the loss of control over limbic impulses. Cocaine addiction is rapidly progressive and associated with severe medical, psychiatric, and psychosocial consequences. Denial shields addicted individuals from their predicament and must be addressed in treatment. Lacking pharmacological options, clinicians must rely entirely on psychosocial approaches. Treatment principles, including engagement, motivational enhancement, abstinence strategies, and craving reduction are discussed in terms of biological rationales.

Citing Articles

RDS04-010: A novel atypical DAT inhibitor that inhibits cocaine taking and seeking and itself has low abuse potential in experimental animals.

Xi Z, Soler-Cedeno O, Galaj E, Klein B, Cao J, Bi G Res Sq. 2024; .

PMID: 39606448 PMC: 11601829. DOI: 10.21203/rs.3.rs-5269973/v1.


Frequent Cocaine Use is Associated With Larger HIV Latent Reservoir Size.

Aouizerat B, Garcia J, Domingues C, Xu K, Quach B, Page G J Acquir Immune Defic Syndr. 2024; 97(2):156-164.

PMID: 39250649 PMC: 11752676. DOI: 10.1097/QAI.0000000000003472.


Disrupted Circadian Rhythms and Substance Use Disorders: A Narrative Review.

Sharma P, Nelson R Clocks Sleep. 2024; 6(3):446-467.

PMID: 39189197 PMC: 11348162. DOI: 10.3390/clockssleep6030030.


Psychosocial interventions for stimulant use disorder.

Minozzi S, Saulle R, Amato L, Traccis F, Agabio R Cochrane Database Syst Rev. 2024; 2:CD011866.

PMID: 38357958 PMC: 10867898. DOI: 10.1002/14651858.CD011866.pub3.


The Relationship between the Brain-Derived Neurotrophic Factor Gene Polymorphism (Val66Met) and Substance Use Disorder and Relapse.

Stronska-Pluta A, Suchanecka A, Chmielowiec K, Chmielowiec J, Boron A, Masiak J Int J Mol Sci. 2024; 25(2).

PMID: 38255861 PMC: 10815198. DOI: 10.3390/ijms25020788.